MGH/Harvard Pediatric Clinical Research Proton Fellowship, 2018-2019
Massachusetts General Hospital
December 21, 2017
Fellowship - Experienced
We are pleased to announce a one-year clinical research fellowship program in pediatric proton radiation therapy at the Massachusetts General Hospital, to begin Summer 2018. The fellow will learn the critical fundamentals of the safe and effective use of proton therapy in the pediatric population and will develop and enhance his/her experience and comfort level with pediatric patients, while honing valuable research skills. The fellow will spend approximately half of the time on clinical radiation oncology services which use proton radiation therapy and the other half of their time on clinical research projects related to proton radiation therapy and its use in the pediatric population. At least one research project will make use of the Pediatric Proton Consortium Registry, a multi-institutional radiation based patient registry based on a consortium of 13 institutions submitting patients and treatment plans, in which over 1900 patients have been enrolled as of December 1, 2017.
The fellow will participate fully in the care of the patient by working with the entire multidisciplinary team and attending long-term follow-up clinics. Central to the clinical experience is participation in radiation planning; the fellow will learn the special considerations that proton therapy dictates and how it differs from photon techniques and where each modality is most appropriately applied. He/she will also attend the multidisciplinary clinical and research rounds that both educate and promote excellent patient care, including: Proton Rounds in the Department of Radiation Oncology; Pediatric Brain Tumor Conference, Sarcoma Conference, Pediatric Tumor Board, and Pediatric (non-CNS) Oncology Conference. The clinical experience serves to provide an excellent introduction to MGH, multidisciplinary care, our proton radiotherapy program, and our critically important clinical research program. It also generates important questions that arise in the process of caring for patients, leading to research project ideas. Additionally, there are ample opportunities for primary authorship and collaborative authorship on multiple different aspects of clinical research in areas such as: late effects and health outcomes; quality of life; protocol development; participation in the pediatric multi-site proton registry; and studies arising from physics-based collaboration. The fellow is expected to be the first author of at least 3 manuscripts and is given opportunities to accomplish this goal within the year. There is also a travel and conference budget, and the fellow is encouraged to attend and present at ASTRO and other relevant pediatric (COG) and particle therapy meetings. By the end of the year the fellow will possess an exceptional understanding of the utility and challenges of proton therapy, and will have gained extensive experience in clinical research, directing projects, protocol development, and outcomes research.
To learn more about pediatric proton therapy at MGH, and the Pediatric Proton Consortium Registry, please visit www.protonsforkids.org and http://www.massgeneral.org/children/services/radiation-therapy-pediatric-proton-consortium-registry.aspx.
To apply, please send your CV, letter of intent, and three letters of recommendation (including a letter from your residency director) to Torunn Yock, MD, MCH at firstname.lastname@example.org and please cc Rachel Strauss at email@example.com. It is acceptable to send the CV and letter initially, followed by the letters of recommendation.
The applicant should have completed residency in Radiation Oncology in the United States or Canada by the start of the fellowship. He/she must have an interest in pediatrics, proton radiotherapy, and clinical research. Qualified applicants with U.S. citizenship are given preference, due to the requirements of the funding source.
This is a one-year fellowship program designed to familiarize the trainee with the indications for, techniques of, and results of proton radiation therapy treatment. Trainees will spend approximately 6 months of the year on clinical radiation oncology services which use proton radiation therapy. Six months of the year will be spent on clinical, physics, or biology research projects related to prot...on radiation therapy and its use in the pediatric population. While on clinical service, the fellow will be expected to evaluate new patients under consideration for proton radiation therapy, dictate appropriate consultation notes, present the patient for discussion at Proton Rounds in the Department of Radiation Oncology and at other appropriate multidisciplinary patient management conferences (i.e. Sarcoma Conference, Pediatric Tumor Board, etc.), review diagnostic studies with the attending Radiation Oncologist and specialists from other services (i.e. Pathology, Diagnostic Radiology), and actively participate in the Proton Radiation Therapy treatment planning process.
MGH has one of the largest pediatric radiation oncology programs in the world. We are the only proton center in New England, and an international referral center for pediatric radiation oncology.